Hospital operators directory 2026

    Private Hospital Groups in Turkey

    Turkey has the largest private hospital sector between Europe and India: roughly 570 private hospitals hold a third of the country’s 260,000 beds, a dozen groups run chains of 10 to 30 hospitals each, and the Social Security Institution’s contracting model means private operators treat publicly insured patients alongside cash and medical-tourism cases.

    The Ministry of Health operates about 900 hospitals including the new city hospitals built under public–private partnerships, universities run 70 teaching hospitals, and private groups — Acıbadem under Malaysia’s IHH, BIST-listed MLP Care, Memorial, Medicana, Florence Nightingale, Medipol and others — have consolidated through acquisitions and international capital since 2010. SGK covers almost the entire population and contracts private hospitals at regulated tariffs with capped co-payments, while 1.5 million medical tourists a year and a growing private-insurance market give groups higher-margin revenue. This directory lists the private hospital groups and operators that matter for pharmaceutical, medical device and diagnostics companies in Turkey, alongside the public systems and payers that shape their formularies and purchasing.

    Updated September 2026 · Ministry of Health Health Statistics Yearbook and General Directorate of Health Services — licensed private hospitals as of September 2026 · 15 named accounts

    Request a proposal for TurkeyBrowse the 15 companies

    ~1,550

    Hospitals in Turkey, around 570 of them private

    ~260,000

    Hospital beds, with private hospitals holding about a third

    ~1.5m

    International patients treated per year, a top-ten global medical-tourism destination

    ~99%

    Population covered by SGK general health insurance

    Named accounts

    Top private hospital groups and operators in Turkey

    Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against Ministry of Health Health Statistics Yearbook and General Directorate of Health Services — licensed private hospitals (as of 2026-09-03).
    #CompanyHQ
    01Acıbadem Healthcare Group (IHH Healthcare)Istanbul
    02MLP Care (Medical Park, VM Medical Park, Liv Hospital)Istanbul
    03Memorial Healthcare GroupIstanbul
    04Medicana Health GroupIstanbul
    05Group Florence NightingaleIstanbul
    06Medipol Health GroupIstanbul
    07Anadolu Medical CenterKocaeli
    08Koç University Hospital and American Hospital (Vehbi Koç Foundation)Istanbul
    09Bayındır Healthcare GroupAnkara
    10Lokman Hekim Health GroupAnkara
    11Dünyagöz Hospitals GroupIstanbul
    12Türkiye Hastanesi and Başkent University HospitalsIstanbul / Ankara
    13Ministry of Health — City Hospitals and State HospitalsAnkara
    14University Hospitals (Hacettepe, Istanbul, Ankara, Ege, Çukurova)Ankara / Istanbul / İzmir
    15Sosyal Güvenlik Kurumu (SGK)Ankara

    Primary research

    These are the hospital operators we work with in Turkey

    Selling into private hospitals in Turkey? BioNixus runs procurement-committee interviews, formulary-listing studies and KOL mapping across the groups above. Proposal ready within 48 hours of a brief.

    Planning research in Turkey?

    Primary research, market access & HEOR. A 30-minute scoping call, then a costed proposal within 48 hours.

    What happens on the call

    • We pin down the decision your research has to support.
    • We check feasibility: respondent types, countries and timeline.
    • You receive a costed proposal within 48 hours of the call.

    Top market research companies in Turkey (2026)

    How the market is structured

    How private hospital provision works in Turkey

    Turkey’s hospital market is large, chained and financed by a single dominant payer. The Social Security Institution covers virtually the whole population, contracts private hospitals under the Health Implementation Communiqué (SUT) at regulated tariffs and permits co-payments of up to 200% for contracted private providers, so most private hospitals treat a mix of SGK-insured, privately insured, cash and international patients. The Ministry of Health’s network — including 20-plus city hospitals of 1,000 to 3,000 beds built under PPP — and university hospitals hold two thirds of beds and buy through the Public Procurement Authority and the State Supply Office, while private groups run central procurement and formulary committees at group level. Acıbadem, majority-owned by IHH Healthcare, is the largest private group with more than 20 hospitals in Turkey plus operations in the Balkans and Netherlands; MLP Care, listed on Borsa Istanbul, runs Medical Park, VM Medical Park and Liv Hospital brands in more than 30 hospitals; Memorial, Medicana, Group Florence Nightingale, Medipol, Bayındır, Lokman Hekim and Türkiye Hastanesi complete the chain tier; Anadolu Medical Center with Johns Hopkins and Koç University Hospital with the American Hospital anchor the academic-private segment; and Dünyagöz shows how specialty chains scale in ophthalmology. Medical tourism from the Gulf, Europe, Russia and Central Asia concentrates in Istanbul and Antalya and sustains premium pricing for oncology, orthopaedics, IVF, aesthetics and hair transplantation. For manufacturers the channel has a public door through PPA and DMO tenders and SGK reimbursement, and a private door through group procurement that negotiates hard on price while adopting innovative therapies and devices faster than public hospitals.

    Local

    Turkish-owned hospital chains, from BIST-listed MLP Care and Lokman Hekim to family and foundation groups such as Medicana, Florence Nightingale and Koç.

    Multinational

    International owners and partners — IHH at Acıbadem, Bain at Memorial, Johns Hopkins at Anadolu — that bring capital and protocols to Turkish hospital groups.

    • Acıbadem Healthcare Group (IHH Healthcare)

    Regional

    Turkish groups that have expanded into the Balkans, the Netherlands and the Gulf, and Gulf investors participating in Turkish healthcare.

    Operators, insurers & public systems

    The Ministry of Health, university hospitals and SGK, which hold most beds, public purchasing and the reimbursement rules that govern every hospital.

    • MLP Care (Medical Park, VM Medical Park, Liv Hospital)
    • Memorial Healthcare Group
    • Medicana Health Group
    • Group Florence Nightingale
    • Medipol Health Group
    • Anadolu Medical Center
    • Koç University Hospital and American Hospital (Vehbi Koç Foundation)
    • Bayındır Healthcare Group
    • Lokman Hekim Health Group
    • Dünyagöz Hospitals Group
    • Türkiye Hastanesi and Başkent University Hospitals
    • Ministry of Health — City Hospitals and State Hospitals
    • University Hospitals (Hacettepe, Istanbul, Ankara, Ege, Çukurova)
    • Sosyal Güvenlik Kurumu (SGK)

    What is moving

    What is moving hospital provision in Turkey

    Medical tourism

    About 1.5 million international patients a year in oncology, orthopaedics, IVF, aesthetics and dental care sustain premium pricing and investment at private groups in Istanbul and Antalya.

    City hospitals and public capacity

    PPP city hospitals of up to 3,000 beds concentrate public procurement and shift patient flows, forcing private groups to specialise and differentiate.

    SGK pricing and currency pressure

    Regulated SUT tariffs and lira depreciation squeeze margins on insured care, pushing groups toward private insurance, international patients and hard procurement negotiation.

    Consolidation and international capital

    IHH, Bain and other investors continue to consolidate hospital groups, centralising formulary and purchasing decisions across dozens of hospitals.

    BioNixus fieldwork

    How BioNixus studies private hospital groups and operators in Turkey

    The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in Turkey:
    • Formulary and procurement decision mapping at Acıbadem, MLP Care, Memorial, Medicana, Medipol and Hacettepe and Istanbul University hospitals.
    • KOL, pharmacy director and hospital purchasing interviews on SUT economics, tender behaviour and specialty-brand adoption.
    • Payer research with SGK stakeholders and private insurers such as Allianz, Anadolu Sigorta and Axa on reimbursement and complementary cover.
    • Patient pathway studies with Turkish and international patients in oncology, cardiology, IVF and orthopaedics across Istanbul, Ankara and Antalya.

    Healthcare market research in Turkey

    Questions

    Frequently Asked Questions

    Which are the largest private hospital groups in Turkey?

    Acıbadem and MLP Care (Medical Park, VM Medical Park, Liv Hospital) are the largest, followed by Memorial, Medicana, Medipol, Group Florence Nightingale, Bayındır and Lokman Hekim, with Anadolu and Koç anchoring the academic-private segment.

    Do private hospitals in Turkey treat publicly insured patients?

    Yes. SGK contracts most private hospitals under regulated tariffs with capped co-payments, so private groups treat SGK-insured patients alongside privately insured, cash and international patients.

    How do Turkish hospitals buy medicines and devices?

    Public hospitals procure through the Public Procurement Authority and the State Supply Office; private groups run central procurement and formulary committees; SGK reimbursement rules govern what is dispensed in both.

    Why is Turkey important for medical tourism?

    Competitive pricing, JCI-accredited private hospitals, geographic access to Europe, the Gulf and Central Asia and government incentives make Turkey a top-ten destination with about 1.5 million international patients a year.

    What does BioNixus study about hospital groups in Turkey?

    Formulary and procurement decision mapping at Acıbadem, MLP Care, Memorial, Medicana and university hospitals; KOL and pharmacy director interviews; SGK and private-insurer research; and account-level brand tracking.

    Is this a ranking of the best hospitals?

    No. This is a B2B directory of operators grouped by role, included because they recur in BioNixus Turkey fieldwork and Ministry of Health statistics; order does not indicate quality or size.

    Sources

    Data sources & methodology

    This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Turkey. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

    Primary register: Ministry of Health Health Statistics Yearbook and General Directorate of Health Services — licensed private hospitals, consulted 2026-09-03. Company classification (Local / MNC / Regional / operators, insurers & public systems) reflects ownership and role in Turkey, not size.

    • Ministry of Health Health Statistics Yearbook, 2023 edition published 2024
    • SGK Health Implementation Communiqué (SUT) and coverage statistics, 2024–2025
    • Borsa Istanbul filings of MLP Care and Lokman Hekim; IHH Healthcare and Memorial disclosures; TÜİK health tourism statistics, 2024–2025
    • BioNixus Turkey hospital and payer fieldwork, 2023–2026

    BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

    48-hour proposal

    Need hospital-level data in Turkey?

    Procurement pathways, formulary status, device usage and clinician preference by operator — fielded with the people who make the decisions.

    Planning research in Turkey?

    Primary research, market access & HEOR. A 30-minute scoping call, then a costed proposal within 48 hours.

    What happens on the call

    • We pin down the decision your research has to support.
    • We check feasibility: respondent types, countries and timeline.
    • You receive a costed proposal within 48 hours of the call.